Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy Bioinductive Implant for Tennis Elbow (Lateral Epicondylitis)
Sponsor: Henry Ford Health System
Summary
The investigators are testing the efficacy of a new, FDA-approved bioinductive patch in lateral epicondylitis (tennis elbow) patients. A bioinductive patch is an implant that may foster tendon regrowth and healing following surgery. Patients will be randomize into one of two groups: control and investigational. Patients in the "control group" will receive the normal surgery for patients who do not respond to physical therapy, lifestyle changes, and anti-inflammatory treatment. Patients in the "experimental group" will receive the same surgical treatment, with the addition of the bioinductive patch. This patch will be implanted during surgery. Then, using a combination of ultrasound studies and other measures, the investigators will assess how well the patch works compared to surgery alone.
Official title: Efficacy Evaluation of Surgical Treatment Using Bioinductive Implant for Tennis Elbow (Lateral Epicondylitis)
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2019-04-17
Completion Date
2027-01-17
Last Updated
2025-03-12
Healthy Volunteers
No
Conditions
Interventions
Smith & Nephew Bioinductive Implant
A bioinductive implant that is supposed to foster healthy tendon regrowth after surgery.
Lateral Epicondylectomy
This procedure is the standard of care for lateral epicondylitis patients who fail conservative treatment options.
Ultrasound Imaging
An ultrasound will be performed on each patient both preoperatively and at 6 months.
Locations (1)
Henry Ford Hospital
Detroit, Michigan, United States